Immuron Limited IMRN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.22M | 5.02M | 4.83M | 4.76M | 4.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.22M | 5.02M | 4.83M | 4.76M | 4.73M |
| Cost of Revenue | 1.85M | 1.80M | 1.75M | 1.69M | 1.63M |
| Gross Profit | 3.37M | 3.22M | 3.08M | 3.07M | 3.09M |
| SG&A Expenses | 5.28M | 5.17M | 5.06M | 5.08M | 5.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -805.70K | -754.10K | -704.10K | -805.00K | -912.20K |
| Total Operating Expenses | 7.63M | 7.77M | 7.91M | 8.02M | 8.19M |
| Operating Income | -2.41M | -2.75M | -3.08M | -3.26M | -3.46M |
| Income Before Tax | -2.49M | -2.74M | -2.99M | -3.17M | -3.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.49 | -2.74 | -2.99 | -3.17 | -3.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.49M | -2.74M | -2.99M | -3.17M | -3.37M |
| EBIT | -2.41M | -2.75M | -3.08M | -3.26M | -3.46M |
| EBITDA | -2.38M | -2.72M | -3.05M | -3.23M | -3.43M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.19B | 1.10B | 1.01B | 969.25M | 923.75M |
| Average Diluted Shares Outstanding | 1.19B | 1.10B | 1.01B | 969.25M | 923.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |